Literature DB >> 19853114

The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005.

Paul H Schipper1, Brian S Diggs, Ross M Ungerleider, Karl F Welke.   

Abstract

BACKGROUND: While general thoracic surgical procedures are performed by several different surgical subspecialties, debate remains as to whether surgeon specialty impacts outcomes.
METHODS: The Nationwide Inpatient Sample (NIS) was queried for procedure codes for pneumonectomy, lobectomy, limited lung resection, and decortication. We constructed multivariate logistic regression models to calculate odds of hospital mortality or length-of-stay (LOS) greater than 14 days (a marker of morbidity), adjusted for age, sex, patient comorbidities, hospital setting, and surgeon specialty. A surgeon was considered general thoracic if they performed greater than 75% general thoracic operations and less than 10% cardiac operations, Cardiac if greater than 10% cardiac operations, and general surgeon if less than 75% general thoracic and less than 10% cardiac operations. A second set of models additionally adjusted for procedure-specific hospital and surgeon volume.
RESULTS: From 1996 to 2005, the NIS estimates 41,808 pneumonectomies, 321,767 lobectomies, 75,200 limited lung resections, and 149,318 decortications were performed in the United States. For all procedures studied, general thoracic surgeons had significantly decreased odds-of-death and LOS greater than 14 days compared with general surgeons. Cardiac surgeons had significantly decreased LOS greater than 14 days for all operations and decreased odds-of-death for decortications, lobectomy, and limited lung resection compared with general surgeons. When further adjusted for surgeon volume, most differences in odds-of-death were no longer present; however, significantly decreased LOS greater than 14 days largely persisted for both general thoracic and cardiac surgeons.
CONCLUSIONS: The majority of general thoracic surgical operations in the United States are performed by surgeons not specializing in thoracic surgery. Both general thoracic surgeons and cardiac surgeons achieve better outcomes than general surgeons. Differences in mortality may be more dependent on surgeon volume than subspecialty. Differences in morbidity are significantly impacted by surgeon specialty and volume.

Entities:  

Mesh:

Year:  2009        PMID: 19853114     DOI: 10.1016/j.athoracsur.2009.08.055

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  27 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 2.  What is quality, and can we define it in lung cancer?-the case for quality improvement.

Authors:  Farhood Farjah; Frank C Detterbeck
Journal:  Transl Lung Cancer Res       Date:  2015-08

3.  Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer.

Authors:  James B Yu; Pamela R Soulos; Laura D Cramer; Roy H Decker; Anthony W Kim; Cary P Gross
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

Review 4.  Preoperative evaluation for lung cancer resection.

Authors:  Dionysios Spyratos; Paul Zarogoulidis; Konstantinos Porpodis; Nikolaos Angelis; Antonios Papaiwannou; Ioannis Kioumis; Georgia Pitsiou; Athanasia Pataka; Kosmas Tsakiridis; Andreas Mpakas; Stamatis Arikas; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Nikolaos Machairiotis; Stavros Siminelakis; Michael Argyriou; Maria Kotsakou; George Kessis; Alexander Kolettas; Thomas Beleveslis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 5.  A decade of advances in treatment of early-stage lung cancer.

Authors:  Luca Paoletti; Nicholas J Pastis; Chadrick E Denlinger; Gerard A Silvestri
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

6.  Risk-Adjusted Margin Positivity Rate as a Surgical Quality Metric for Non-Small Cell Lung Cancer.

Authors:  Chun Chieh Lin; Matthew P Smeltzer; Ahmedin Jemal; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2017-07-12       Impact factor: 4.330

7.  Neighborly Help or Itinerant Surgery?

Authors:  James S Allan; Alberto Ferreres; Robert M Sade
Journal:  Ann Thorac Surg       Date:  2018-10-10       Impact factor: 4.330

8.  Socioeconomic risk factors for long-term mortality after pulmonary resection for lung cancer: an analysis of more than 90,000 patients from the National Cancer Data Base.

Authors:  Onkar V Khullar; Theresa Gillespie; Dana C Nickleach; Yuan Liu; Kristin Higgins; Suresh Ramalingam; Joseph Lipscomb; Felix G Fernandez
Journal:  J Am Coll Surg       Date:  2014-10-27       Impact factor: 6.113

9.  Determinants of surgical decision making: a national survey.

Authors:  Niamey P Wilson; Francis P Wilson; Mark Neuman; Andrew Epstein; Richard Bell; Katrina Armstrong; Kenric Murayama
Journal:  Am J Surg       Date:  2013-12       Impact factor: 2.565

10.  Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?

Authors:  Pamela Samson; Aalok Patel; Traves D Crabtree; Daniel Morgensztern; Cliff G Robinson; Graham A Colditz; Saiama Waqar; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Stephen Broderick; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2015-07-28       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.